Clinical Progression Scale-Pediatrics: A Potential Metric of Respiratory Syncytial Virus Severity and Progression in Children - Top-Institutions - MDSpire

Clinical Progression Scale-Pediatrics: A Potential Metric of Respiratory Syncytial Virus Severity and Progression in Children

  • By

  • Gabriella Ess

  • Christina A Rostad

  • January 10, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Children's Hospital of Philadelphia
    Children's Hospital of Philadelphia

    Philadelphia, PA

    Key Differentiators

    • Pediatric Infectious Diseases
    • Pediatric Pulmonology
    • Clinical Research

  • #2

    Seattle Children's Hospital
    Seattle Children's Hospital

    Seattle, WA

    Key Differentiators

    • Pediatric Infectious Diseases
    • Critical Care Medicine
    • Immunology

  • #3

    Boston Children's Hospital
    Boston Children's Hospital

    Boston, MA

    Key Differentiators

    • Pediatric Infectious Diseases
    • Pulmonology
    • Clinical Epidemiology

  • #4

    Johns Hopkins Children's Center
    Johns Hopkins Children's Center

    Baltimore, MD

    Key Differentiators

    • Pediatric Infectious Diseases
    • Critical Care
    • Translational Research

  • #5

    University of Utah Health - Primary Children's Hospital
    University of Utah Health - Primary Children's Hospital

    Salt Lake City, UT

    Key Differentiators

    • Pediatric Infectious Diseases
    • Pulmonology
    • Clinical Trials

Original Source(s)

Clinical Progression Scale-Pediatrics: A Potential Metric of Respiratory Syncytial Virus Severity and Progression in Children

  • by Gabriella Ess, Christina A Rostad

  • January 10, 2025

Related Content

AAE Revises Dental Trauma Guidance

Recommendations outline splinting, replantation timing, imaging, and long-term surveillance strategies for permanent tooth injuries.

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Senate Report Details Early Myocarditis Signals After COVID-19 Vaccination

Investigative report cites internal communications, VAERS data, and CDC case reviews describing myocarditis and pericarditis reports in adolescents and young adults after mRNA COVID-19 vaccination.